ResGen Limited (BOM:543805)
India · Delayed Price · Currency is INR 45.00
+1.26 (2.88%)
At close: Oct 5, 2026
ResGen Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Other Revenue | -0 | 0 | - | - | - |
| 710.78 | 651.59 | 455.02 | 235.83 | 48.08 | |
Revenue Growth | 9.08% | 43.20% | 92.94% | 390.48% | 23940.50% |
Cost of Revenue | 550.62 | 481.69 | 291.13 | 125.07 | 25.61 |
Gross Profit | 160.17 | 169.9 | 163.88 | 110.76 | 22.47 |
Selling, General & Admin | 11.31 | 8.03 | 6.37 | 2.91 | 0.32 |
Other Operating Expenses | 10.03 | 7.5 | 4.78 | 4.83 | 2.02 |
Operating Expenses | 49.49 | 51.28 | 60.43 | 37.31 | 8.98 |
Operating Income | 110.68 | 118.63 | 103.46 | 73.45 | 13.49 |
Interest Expense | -5.47 | -5.53 | -11 | -14.49 | -3.05 |
Earnings From Equity Investments | 14.27 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.01 | -1.76 | -0.32 | -0.01 | -0.01 |
EBT Excluding Unusual Items | 119.47 | 111.34 | 92.14 | 58.95 | 10.43 |
Other Unusual Items | 16.42 | 0.01 | -0.35 | -0.41 | - |
Pretax Income | 135.89 | 111.35 | 91.78 | 58.54 | 10.43 |
Income Tax Expense | 33.91 | 31.6 | 26.1 | 16.85 | 2.86 |
Net Income | 101.98 | 79.75 | 65.69 | 41.69 | 7.58 |
Net Income to Common | 101.98 | 79.75 | 65.69 | 41.69 | 7.58 |
Net Income Growth | 27.86% | 21.41% | 57.56% | 450.22% | 11926.98% |
Shares Outstanding (Basic) | 21 | 21 | 21 | 14 | 13 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 14 | 13 |
Shares Change | - | - | 52.95% | 9.42% | 4.22% |
EPS (Basic) | 4.86 | 3.80 | 3.13 | 3.04 | 0.60 |
EPS (Diluted) | 4.86 | 3.80 | 3.13 | 3.04 | 0.60 |
EPS Growth | 27.89% | 21.41% | 2.96% | 406.67% | 11352.55% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 39.01 | 59.07 | -35.88 | -231.63 | -110.99 |
Free Cash Flow Per Share | 1.86 | 2.82 | -1.71 | -16.89 | -8.86 |
Gross Margin | 22.53% | 26.07% | 36.02% | 46.97% | 46.73% |
Operating Margin | 15.57% | 18.20% | 22.74% | 31.15% | 28.06% |
Profit Margin | 14.35% | 12.24% | 14.44% | 17.68% | 15.76% |
Free Cash Flow Margin | 5.49% | 9.07% | -7.89% | -98.22% | -230.85% |
EBITDA | 138.83 | 154.38 | 152.72 | 103.02 | 20.13 |
EBITDA Margin | 19.53% | 23.69% | 33.56% | 43.69% | 41.87% |
D&A For EBITDA | 28.15 | 35.75 | 49.27 | 29.57 | 6.64 |
EBIT | 110.68 | 118.63 | 103.46 | 73.45 | 13.49 |
EBIT Margin | 15.57% | 18.20% | 22.74% | 31.15% | 28.06% |
Effective Tax Rate | 24.96% | 28.38% | 28.43% | 28.79% | 27.37% |
Revenue as Reported | 727.2 | 651.61 | 455.74 | 235.88 | 48.08 |
Advertising Expenses | 0.07 | 1.06 | 1.68 | 0.56 | 0.04 |